Strumento inattivo

Azioni Kun Run Biotechnology, Inc.

Azioni

Durata

Periodo

Stile

KUN RUN BIOTCH : Kun Run Biotechnology Announces That They Have Obtained the Manufacturing Approval for Entecavir from the China State Food and Drug Administration	17/06/10
KUN RUN BIOTCH : Kun Run Biotechnology, Inc. Executes Purchase Agreements for Approximately $8 Million Private Placement	22/04/10
KUN RUN BIOTCH : Kun Run Biotechnology Reports Fourth Quarter and Fiscal Year 2009 Financial Results	30/03/10
KUN RUN BIOTCH : Kun Run Biotechnology, Inc. Announces Third Quarter 2009 Results	13/11/09
KUN RUN BIOTECHNLG : Kun Run Biotechnology, Inc. Year-End Revenues Increase 56% to $11.6 million	01/04/09

Settore

	Variaz. 1 gen.	Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19,62%	43,34 Mrd
OTSUKA HOLDINGS CO., LTD.	+20,44%	21,96 Mrd
SANDOZ GROUP AG	+10,86%	14,09 Mrd
CIPLA LIMITED	+13,07%	13,64 Mrd
ZYDUS LIFESCIENCES LIMITED	+37,46%	11,43 Mrd
ONO PHARMACEUTICAL CO., LTD.	-8,59%	6,86 Mrd
THE MEDICINES COMPANY	-0,05%	6,79 Mrd
STADA ARZNEIMITTEL	-8,87%	5,73 Mrd
ASPEN PHARMACARE HOLDINGS LIMITED	+8,46%	5,22 Mrd